323 / 604
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0 10 20 30 40 50 60 70 80 90 100
max. follow up (mos.)
SC-RT
LC-RT
Group E,
P = 0.002
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0 10 20 30 40 50 60 70 80 90 100110
max. follow up (mos.)
SC-RT
LC-RT
Group D,
P = 0.011
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
1 2 3 4 5 6 7 8 9 10 11 12
max. follow up (mos.)
SC-RT
LC-RT
Group A,
P = 0.93
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0 2 4 6 8 10 12 14 16 18
max. follow up (mos.)
SC-RT
LC-RT
Group B,
P = 0.47
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0 10 20 30 40 50 60
max. follow up (mos.)
SC-RT
Group C,
P = 0.73
Rades et al., Cancer 2008
38
Voorspellen overleving en mobiliteit